Financials
Eisai: FYE Mar 2026 and ten years of results (46 metrics)
FYE Mar 2026 · Revenue¥825bnYoY +4.6%
FYE Mar 2026 · Operating profit¥44bnYoY −18.8%
FYE Mar 2026 · Net profit¥39bnYoY −17.0%
FYE Mar 2026 · Equity ratio60.2%YoY +1.3pp
FYE Mar 2026 · Group employees10,543YoY −374
| Fiscal year | Revenue | YoY | Operating profit | YoY | Margin | Net profit | Chief executive | That year |
|---|---|---|---|---|---|---|---|---|
| FYE Mar 2017Consolidated | ¥539bn | n/a | ¥59bn | n/a | 11.0% | ¥39bn | Naito Haruo | — |
| FYE Mar 2018Consolidated | ¥600bn | +11.3% | ¥77bn | +30.7% | 12.9% | ¥52bn | Naito Haruo | — |
| FYE Mar 2019Consolidated | ¥643bn | +7.1% | ¥86bn | +11.6% | 13.4% | ¥63bn | Naito Haruo | Worldwide alliance with Merck & Co. on Lenvima |
| FYE Mar 2020Consolidated | ¥696bn | +8.2% | ¥126bn | +45.7% | 18.0% | ¥122bn | Naito Haruo | The G202 discovery research laboratory is established in July |
| FYE Mar 2021Consolidated | ¥646bn | −7.1% | ¥52bn | −58.8% | 8.0% | ¥42bn | Naito Haruo | — |
| FYE Mar 2022Consolidated | ¥756bn | +17.1% | ¥54bn | +3.8% | 7.1% | ¥48bn | Naito Haruo | — |
| FYE Mar 2023Consolidated | ¥744bn | −1.6% | ¥40bn | −25.5% | 5.4% | ¥55bn | Naito Haruo | Lecanemab meets its primary endpoint in September |
| FYE Mar 2024Consolidated | ¥742bn | −0.4% | ¥53bn | +33.4% | 7.2% | ¥42bn | Naito Haruo | Leqembi wins full FDA approval in the United States in July |
| FYE Mar 2025Consolidated | ¥789bn | +6.4% | ¥54bn | +1.8% | 6.9% | ¥46bn | Naito Haruo | — |
| FYE Mar 2026Consolidated | ¥825bn | +4.6% | ¥44bn | −18.8% | 5.3% | ¥39bn | Naito Haruo | — |
How it compares
Takeda Pharmaceutical¥4.51tnFY2025Operating margin 0.1%Otsuka Holdings¥2.47tnFY2025Operating margin 19.4%Astellas Pharma¥2.14tnFY2025Operating margin 17.9%Daiichi Sankyo¥2.12tnFY2025Operating margin 10.8%Chugai Pharmaceutical¥1.26tnFY2025Operating margin 47.6%
Eisai¥825bnFY2025Operating margin 5.3%
Yamanouchi Pharmaceutical Co., Ltd.Dissolved 2005
Shionogi¥500bnFY2025Operating margin 33.4%Sumitomo Pharma¥453bnFY2025Operating margin 23.7%Mitsubishi Tanabe Pharma CorporationDissolved 2020
Income statement Revenue, costs, each level of profit and the margins they leave
Where the revenue goes
¥ bnMargins
%Revenue net sales, operating revenue
FYE Mar 2026 ¥825bn
CAGR · 10 yrs +4.8%
| Fiscal year | Revenue ¥ bn | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | 539 | n/a | Cons. · IFRS |
| FYE Mar 2018 | 600 | +11.3% | Cons. · IFRS |
| FYE Mar 2019 | 643 | +7.1% | Cons. · IFRS |
| FYE Mar 2020 | 696 | +8.2% | Cons. · IFRS |
| FYE Mar 2021 | 646 | −7.1% | Cons. · IFRS |
| FYE Mar 2022 | 756 | +17.1% | Cons. · IFRS |
| FYE Mar 2023 | 744 | −1.6% | Cons. · IFRS |
| FYE Mar 2024 | 742 | −0.4% | Cons. · IFRS |
| FYE Mar 2025 | 789 | +6.4% | Cons. · IFRS |
| FYE Mar 2026 | 825 | +4.6% | Cons. · IFRS |
Cost of sales
FYE Mar 2026 ¥191bn
CAGR · 10 yrs −0.3%
| Fiscal year | Cost of sales ¥ bn | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | 196 | n/a | Cons. · IFRS |
| FYE Mar 2018 | 201 | +2.7% | Cons. · IFRS |
| FYE Mar 2019 | 184 | −8.3% | Cons. · IFRS |
| FYE Mar 2020 | 176 | −4.8% | Cons. · IFRS |
| FYE Mar 2021 | 161 | −8.2% | Cons. · IFRS |
| FYE Mar 2022 | 175 | +8.4% | Cons. · IFRS |
| FYE Mar 2023 | 178 | +1.7% | Cons. · IFRS |
| FYE Mar 2024 | 155 | −12.7% | Cons. · IFRS |
| FYE Mar 2025 | 169 | +8.7% | Cons. · IFRS |
| FYE Mar 2026 | 191 | +13.3% | Cons. · IFRS |
Gross profit
FYE Mar 2026 ¥634bn
CAGR · 10 yrs +7.1%
| Fiscal year | Gross profit ¥ bn | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | 343 | n/a | Cons. · IFRS |
| FYE Mar 2018 | 399 | +16.2% | Cons. · IFRS |
| FYE Mar 2019 | 458 | +14.9% | Cons. · IFRS |
| FYE Mar 2020 | 520 | +13.4% | Cons. · IFRS |
| FYE Mar 2021 | 485 | −6.8% | Cons. · IFRS |
| FYE Mar 2022 | 581 | +20.0% | Cons. · IFRS |
| FYE Mar 2023 | 567 | −2.6% | Cons. · IFRS |
| FYE Mar 2024 | 586 | +3.5% | Cons. · IFRS |
| FYE Mar 2025 | 621 | +5.8% | Cons. · IFRS |
| FYE Mar 2026 | 634 | +2.2% | Cons. · IFRS |
SG&A selling, general and administrative expenses
FYE Mar 2026 ¥435bn
CAGR · 10 yrs +4.5%
| Fiscal year | SG&A ¥ bn | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | 292 | n/a | Cons. · IFRS |
| FYE Mar 2018 | 184 | −37.1% | Cons. · IFRS |
| FYE Mar 2019 | 228 | +24.1% | Cons. · IFRS |
| FYE Mar 2020 | 256 | +12.3% | Cons. · IFRS |
| FYE Mar 2021 | 281 | +9.8% | Cons. · IFRS |
| FYE Mar 2022 | 366 | +30.2% | Cons. · IFRS |
| FYE Mar 2023 | 358 | −2.2% | Cons. · IFRS |
| FYE Mar 2024 | 374 | +4.5% | Cons. · IFRS |
| FYE Mar 2025 | 408 | +9.0% | Cons. · IFRS |
| FYE Mar 2026 | 435 | +6.7% | Cons. · IFRS |
Operating profit
FYE Mar 2026 ¥44bn
CAGR · 10 yrs −3.2%
| Fiscal year | Operating profit ¥ bn | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | 59.1 | n/a | Cons. · IFRS |
| FYE Mar 2018 | 77.2 | +30.7% | Cons. · IFRS |
| FYE Mar 2019 | 86.2 | +11.6% | Cons. · IFRS |
| FYE Mar 2020 | 126 | +45.7% | Cons. · IFRS |
| FYE Mar 2021 | 51.8 | −58.8% | Cons. · IFRS |
| FYE Mar 2022 | 53.8 | +3.8% | Cons. · IFRS |
| FYE Mar 2023 | 40.0 | −25.5% | Cons. · IFRS |
| FYE Mar 2024 | 53.4 | +33.4% | Cons. · IFRS |
| FYE Mar 2025 | 54.4 | +1.8% | Cons. · IFRS |
| FYE Mar 2026 | 44.1 | −18.8% | Cons. · IFRS |
Non-operating income
FYE Mar 2026 ¥12bn
CAGR · 10 yrs +23.3%
| Fiscal year | Non-operating income ¥ bn | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | 1.8 | n/a | Cons. · IFRS |
| FYE Mar 2018 | 2.6 | +38.3% | Cons. · IFRS |
| FYE Mar 2019 | 4.9 | +90.2% | Cons. · IFRS |
| FYE Mar 2020 | 4.0 | −17.2% | Cons. · IFRS |
| FYE Mar 2021 | 2.1 | −46.7% | Cons. · IFRS |
| FYE Mar 2022 | 2.4 | +11.9% | Cons. · IFRS |
| FYE Mar 2023 | 7.2 | +201.5% | Cons. · IFRS |
| FYE Mar 2024 | 10.8 | +49.2% | Cons. · IFRS |
| FYE Mar 2025 | 10.2 | −5.5% | Cons. · IFRS |
| FYE Mar 2026 | 12.2 | +19.5% | Cons. · IFRS |
Non-operating expenses
FYE Mar 2026 ¥5.3bn
CAGR · 10 yrs +5.7%
| Fiscal year | Non-operating expenses ¥ bn | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | 3.2 | n/a | Cons. · IFRS |
| FYE Mar 2018 | 3.0 | −8.6% | Cons. · IFRS |
| FYE Mar 2019 | 1.6 | −47.5% | Cons. · IFRS |
| FYE Mar 2020 | 1.5 | −6.2% | Cons. · IFRS |
| FYE Mar 2021 | 1.4 | −7.0% | Cons. · IFRS |
| FYE Mar 2022 | 1.7 | +24.4% | Cons. · IFRS |
| FYE Mar 2023 | 2.3 | +33.9% | Cons. · IFRS |
| FYE Mar 2024 | 2.4 | +5.4% | Cons. · IFRS |
| FYE Mar 2025 | 3.5 | +47.4% | Cons. · IFRS |
| FYE Mar 2026 | 5.3 | +51.6% | Cons. · IFRS |
Net profit profit attributable to owners of the parent
FYE Mar 2026 ¥39bn
CAGR · 10 yrs −0.2%
| Fiscal year | Net profit ¥ bn | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | 39.4 | n/a | Cons. · IFRS |
| FYE Mar 2018 | 51.8 | +31.7% | Cons. · IFRS |
| FYE Mar 2019 | 63.4 | +22.3% | Cons. · IFRS |
| FYE Mar 2020 | 122 | +92.1% | Cons. · IFRS |
| FYE Mar 2021 | 41.9 | −65.6% | Cons. · IFRS |
| FYE Mar 2022 | 48.0 | +14.3% | Cons. · IFRS |
| FYE Mar 2023 | 55.4 | +15.6% | Cons. · IFRS |
| FYE Mar 2024 | 42.4 | −23.5% | Cons. · IFRS |
| FYE Mar 2025 | 46.4 | +9.5% | Cons. · IFRS |
| FYE Mar 2026 | 38.6 | −17.0% | Cons. · IFRS |
Gross margin
FYE Mar 2026 76.8%
Average · 10 yrs 73.9%
| Fiscal year | Gross margin % | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | 63.7 | n/a | Cons. · IFRS |
| FYE Mar 2018 | 66.5 | +2.8pp | Cons. · IFRS |
| FYE Mar 2019 | 71.3 | +4.8pp | Cons. · IFRS |
| FYE Mar 2020 | 74.7 | +3.4pp | Cons. · IFRS |
| FYE Mar 2021 | 75.0 | +0.3pp | Cons. · IFRS |
| FYE Mar 2022 | 76.9 | +1.9pp | Cons. · IFRS |
| FYE Mar 2023 | 76.1 | −0.8pp | Cons. · IFRS |
| FYE Mar 2024 | 79.1 | +2.9pp | Cons. · IFRS |
| FYE Mar 2025 | 78.6 | −0.4pp | Cons. · IFRS |
| FYE Mar 2026 | 76.8 | −1.8pp | Cons. · IFRS |
Operating margin
FYE Mar 2026 5.3%
Average · 10 yrs 9.5%
| Fiscal year | Operating margin % | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | 11.0 | n/a | Cons. · IFRS |
| FYE Mar 2018 | 12.9 | +1.9pp | Cons. · IFRS |
| FYE Mar 2019 | 13.4 | +0.5pp | Cons. · IFRS |
| FYE Mar 2020 | 18.0 | +4.6pp | Cons. · IFRS |
| FYE Mar 2021 | 8.0 | −10.0pp | Cons. · IFRS |
| FYE Mar 2022 | 7.1 | −0.9pp | Cons. · IFRS |
| FYE Mar 2023 | 5.4 | −1.7pp | Cons. · IFRS |
| FYE Mar 2024 | 7.2 | +1.8pp | Cons. · IFRS |
| FYE Mar 2025 | 6.9 | −0.3pp | Cons. · IFRS |
| FYE Mar 2026 | 5.3 | −1.5pp | Cons. · IFRS |
Net margin
FYE Mar 2026 4.7%
Average · 10 yrs 8.0%
| Fiscal year | Net margin % | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | 7.3 | n/a | Cons. · IFRS |
| FYE Mar 2018 | 8.6 | +1.3pp | Cons. · IFRS |
| FYE Mar 2019 | 9.9 | +1.2pp | Cons. · IFRS |
| FYE Mar 2020 | 17.5 | +7.6pp | Cons. · IFRS |
| FYE Mar 2021 | 6.5 | −11.0pp | Cons. · IFRS |
| FYE Mar 2022 | 6.3 | −0.2pp | Cons. · IFRS |
| FYE Mar 2023 | 7.4 | +1.1pp | Cons. · IFRS |
| FYE Mar 2024 | 5.7 | −1.7pp | Cons. · IFRS |
| FYE Mar 2025 | 5.9 | +0.2pp | Cons. · IFRS |
| FYE Mar 2026 | 4.7 | −1.2pp | Cons. · IFRS |
Cost-of-sales ratio
FYE Mar 2026 23.2%
Average · 10 yrs 26.1%
| Fiscal year | Cost-of-sales ratio % | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | 36.3 | n/a | Cons. · IFRS |
| FYE Mar 2018 | 33.5 | −2.8pp | Cons. · IFRS |
| FYE Mar 2019 | 28.7 | −4.8pp | Cons. · IFRS |
| FYE Mar 2020 | 25.3 | −3.4pp | Cons. · IFRS |
| FYE Mar 2021 | 25.0 | −0.3pp | Cons. · IFRS |
| FYE Mar 2022 | 23.1 | −1.9pp | Cons. · IFRS |
| FYE Mar 2023 | 23.9 | +0.8pp | Cons. · IFRS |
| FYE Mar 2024 | 20.9 | −2.9pp | Cons. · IFRS |
| FYE Mar 2025 | 21.4 | +0.4pp | Cons. · IFRS |
| FYE Mar 2026 | 23.2 | +1.8pp | Cons. · IFRS |
SG&A ratio
FYE Mar 2026 52.7%
Average · 10 yrs 45.2%
| Fiscal year | SG&A ratio % | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | 54.2 | n/a | Cons. · IFRS |
| FYE Mar 2018 | 30.6 | −23.6pp | Cons. · IFRS |
| FYE Mar 2019 | 35.5 | +4.9pp | Cons. · IFRS |
| FYE Mar 2020 | 36.8 | +1.3pp | Cons. · IFRS |
| FYE Mar 2021 | 43.6 | +6.7pp | Cons. · IFRS |
| FYE Mar 2022 | 48.5 | +4.9pp | Cons. · IFRS |
| FYE Mar 2023 | 48.1 | −0.3pp | Cons. · IFRS |
| FYE Mar 2024 | 50.5 | +2.3pp | Cons. · IFRS |
| FYE Mar 2025 | 51.7 | +1.2pp | Cons. · IFRS |
| FYE Mar 2026 | 52.7 | +1.1pp | Cons. · IFRS |
Balance sheet Assets, debt and equity, and what they say about financial strength
What the balance sheet is made of
¥ bnFinancial strength
%Total assets
FYE Mar 2026 ¥1.45tn
CAGR · 10 yrs +3.9%
| Fiscal year | Total assets ¥ bn | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | 1,031 | n/a | Cons. · IFRS |
| FYE Mar 2018 | 1,049 | +1.8% | Cons. · IFRS |
| FYE Mar 2019 | 1,072 | +2.1% | Cons. · IFRS |
| FYE Mar 2020 | 1,062 | −0.9% | Cons. · IFRS |
| FYE Mar 2021 | 1,088 | +2.5% | Cons. · IFRS |
| FYE Mar 2022 | 1,239 | +13.9% | Cons. · IFRS |
| FYE Mar 2023 | 1,263 | +1.9% | Cons. · IFRS |
| FYE Mar 2024 | 1,394 | +10.3% | Cons. · IFRS |
| FYE Mar 2025 | 1,387 | −0.5% | Cons. · IFRS |
| FYE Mar 2026 | 1,449 | +4.5% | Cons. · IFRS |
Equity net assets, shareholders' equity
FYE Mar 2026 ¥873bn
CAGR · 10 yrs +4.6%
| Fiscal year | Equity ¥ bn | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | 585 | n/a | Cons. · IFRS |
| FYE Mar 2018 | 573 | −2.0% | Cons. · IFRS |
| FYE Mar 2019 | 604 | +5.4% | Cons. · IFRS |
| FYE Mar 2020 | 654 | +8.2% | Cons. · IFRS |
| FYE Mar 2021 | 677 | +3.6% | Cons. · IFRS |
| FYE Mar 2022 | 726 | +7.3% | Cons. · IFRS |
| FYE Mar 2023 | 777 | +7.1% | Cons. · IFRS |
| FYE Mar 2024 | 852 | +9.6% | Cons. · IFRS |
| FYE Mar 2025 | 817 | −4.2% | Cons. · IFRS |
| FYE Mar 2026 | 873 | +6.9% | Cons. · IFRS |
Interest-bearing debt
FYE Mar 2026 ¥186bn
CAGR · 9 yrs +0.9%
| Fiscal year | Interest-bearing debt ¥ bn | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | n/a | n/a | Cons. · IFRS |
| FYE Mar 2018 | 173 | n/a | Cons. · IFRS |
| FYE Mar 2019 | 139 | −19.8% | Cons. · IFRS |
| FYE Mar 2020 | 89.9 | −35.2% | Cons. · IFRS |
| FYE Mar 2021 | 89.9 | −0.1% | Cons. · IFRS |
| FYE Mar 2022 | 94.9 | +5.6% | Cons. · IFRS |
| FYE Mar 2023 | 126 | +32.9% | Cons. · IFRS |
| FYE Mar 2024 | 159 | +26.4% | Cons. · IFRS |
| FYE Mar 2025 | 188 | +17.6% | Cons. · IFRS |
| FYE Mar 2026 | 186 | −0.8% | Cons. · IFRS |
Short-term borrowings
FYE Mar 2026 ¥51bn
CAGR · 8 yrs +17.7%
| Fiscal year | Short-term borrowings ¥ bn | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | n/a | n/a | Cons. · IFRS |
| FYE Mar 2018 | 16.4 | n/a | Cons. · IFRS |
| FYE Mar 2019 | 49.0 | +198.7% | Cons. · IFRS |
| FYE Mar 2020 | 35.0 | −28.6% | Cons. · IFRS |
| FYE Mar 2021 | 40.0 | +14.3% | Cons. · IFRS |
| FYE Mar 2022 | n/a | n/a | Cons. · IFRS |
| FYE Mar 2023 | 41.2 | n/a | Cons. · IFRS |
| FYE Mar 2024 | 24.6 | −40.2% | Cons. · IFRS |
| FYE Mar 2025 | 87.7 | +256.0% | Cons. · IFRS |
| FYE Mar 2026 | 51.3 | −41.5% | Cons. · IFRS |
Long-term borrowings
FYE Mar 2026 ¥135bn
CAGR · 9 yrs −1.9%
| Fiscal year | Long-term borrowings ¥ bn | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | n/a | n/a | Cons. · IFRS |
| FYE Mar 2018 | 157 | n/a | Cons. · IFRS |
| FYE Mar 2019 | 89.9 | −42.6% | Cons. · IFRS |
| FYE Mar 2020 | 54.9 | −38.9% | Cons. · IFRS |
| FYE Mar 2021 | 49.9 | −9.2% | Cons. · IFRS |
| FYE Mar 2022 | 94.9 | +90.1% | Cons. · IFRS |
| FYE Mar 2023 | 84.9 | −10.5% | Cons. · IFRS |
| FYE Mar 2024 | 135 | +58.7% | Cons. · IFRS |
| FYE Mar 2025 | 99.8 | −25.9% | Cons. · IFRS |
| FYE Mar 2026 | 135 | +35.0% | Cons. · IFRS |
Intangible assets
FYE Mar 2026 ¥88bn
CAGR · 9 yrs −2.4%
| Fiscal year | Intangible assets ¥ bn | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | n/a | n/a | Cons. · IFRS |
| FYE Mar 2018 | 107 | n/a | Cons. · IFRS |
| FYE Mar 2019 | 98.1 | −8.7% | Cons. · IFRS |
| FYE Mar 2020 | 106 | +8.1% | Cons. · IFRS |
| FYE Mar 2021 | 106 | +0.3% | Cons. · IFRS |
| FYE Mar 2022 | 95.5 | −10.3% | Cons. · IFRS |
| FYE Mar 2023 | 89.2 | −6.5% | Cons. · IFRS |
| FYE Mar 2024 | 85.5 | −4.2% | Cons. · IFRS |
| FYE Mar 2025 | 75.3 | −12.0% | Cons. · IFRS |
| FYE Mar 2026 | 88.1 | +17.1% | Cons. · IFRS |
Goodwill
FYE Mar 2026 ¥259bn
CAGR · 10 yrs +4.5%
| Fiscal year | Goodwill ¥ bn | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | 174 | n/a | Cons. · IFRS |
| FYE Mar 2018 | 165 | −5.2% | Cons. · IFRS |
| FYE Mar 2019 | 172 | +4.4% | Cons. · IFRS |
| FYE Mar 2020 | 169 | −2.0% | Cons. · IFRS |
| FYE Mar 2021 | 172 | +1.8% | Cons. · IFRS |
| FYE Mar 2022 | 192 | +11.6% | Cons. · IFRS |
| FYE Mar 2023 | 209 | +8.9% | Cons. · IFRS |
| FYE Mar 2024 | 236 | +13.2% | Cons. · IFRS |
| FYE Mar 2025 | 233 | −1.2% | Cons. · IFRS |
| FYE Mar 2026 | 259 | +11.0% | Cons. · IFRS |
Equity ratio
FYE Mar 2026 60.2%
Average · 10 yrs 59.2%
| Fiscal year | Equity ratio % | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | 56.7 | n/a | Cons. · IFRS |
| FYE Mar 2018 | 54.6 | −2.1pp | Cons. · IFRS |
| FYE Mar 2019 | 56.4 | +1.8pp | Cons. · IFRS |
| FYE Mar 2020 | 61.5 | +5.1pp | Cons. · IFRS |
| FYE Mar 2021 | 62.2 | +0.6pp | Cons. · IFRS |
| FYE Mar 2022 | 58.6 | −3.6pp | Cons. · IFRS |
| FYE Mar 2023 | 61.5 | +2.9pp | Cons. · IFRS |
| FYE Mar 2024 | 61.1 | −0.4pp | Cons. · IFRS |
| FYE Mar 2025 | 58.9 | −2.2pp | Cons. · IFRS |
| FYE Mar 2026 | 60.2 | +1.3pp | Cons. · IFRS |
Debt-to-equity ratio D/E ratio
FYE Mar 2026 21.3%
Average · 9 yrs 19.2%
| Fiscal year | Debt-to-equity ratio % | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | n/a | n/a | Cons. · IFRS |
| FYE Mar 2018 | 30.2 | n/a | Cons. · IFRS |
| FYE Mar 2019 | 23.0 | −7.2pp | Cons. · IFRS |
| FYE Mar 2020 | 13.8 | −9.2pp | Cons. · IFRS |
| FYE Mar 2021 | 13.3 | −0.5pp | Cons. · IFRS |
| FYE Mar 2022 | 13.1 | −0.2pp | Cons. · IFRS |
| FYE Mar 2023 | 16.2 | +3.2pp | Cons. · IFRS |
| FYE Mar 2024 | 18.7 | +2.5pp | Cons. · IFRS |
| FYE Mar 2025 | 23.0 | +4.3pp | Cons. · IFRS |
| FYE Mar 2026 | 21.3 | −1.6pp | Cons. · IFRS |
ROE return on equity
FYE Mar 2026 4.4%
Average · 10 yrs 8.0%
| Fiscal year | ROE % | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | 6.7 | n/a | Cons. · IFRS |
| FYE Mar 2018 | 9.0 | +2.3pp | Cons. · IFRS |
| FYE Mar 2019 | 10.5 | +1.4pp | Cons. · IFRS |
| FYE Mar 2020 | 18.6 | +8.1pp | Cons. · IFRS |
| FYE Mar 2021 | 6.2 | −12.4pp | Cons. · IFRS |
| FYE Mar 2022 | 6.6 | +0.4pp | Cons. · IFRS |
| FYE Mar 2023 | 7.1 | +0.5pp | Cons. · IFRS |
| FYE Mar 2024 | 5.0 | −2.2pp | Cons. · IFRS |
| FYE Mar 2025 | 5.7 | +0.7pp | Cons. · IFRS |
| FYE Mar 2026 | 4.4 | −1.3pp | Cons. · IFRS |
ROA return on assets
FYE Mar 2026 2.7%
Average · 10 yrs 4.7%
| Fiscal year | ROA % | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | 3.8 | n/a | Cons. · IFRS |
| FYE Mar 2018 | 4.9 | +1.1pp | Cons. · IFRS |
| FYE Mar 2019 | 5.9 | +1.0pp | Cons. · IFRS |
| FYE Mar 2020 | 11.5 | +5.5pp | Cons. · IFRS |
| FYE Mar 2021 | 3.9 | −7.6pp | Cons. · IFRS |
| FYE Mar 2022 | 3.9 | −0.0pp | Cons. · IFRS |
| FYE Mar 2023 | 4.4 | +0.5pp | Cons. · IFRS |
| FYE Mar 2024 | 3.0 | −1.3pp | Cons. · IFRS |
| FYE Mar 2025 | 3.3 | +0.3pp | Cons. · IFRS |
| FYE Mar 2026 | 2.7 | −0.7pp | Cons. · IFRS |
Asset turnover
FYE Mar 2026 0.57×
CAGR · 10 yrs +1.0%
| Fiscal year | Asset turnover × | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | 0.52 | n/a | Cons. · IFRS |
| FYE Mar 2018 | 0.57 | +9.4% | Cons. · IFRS |
| FYE Mar 2019 | 0.60 | +4.9% | Cons. · IFRS |
| FYE Mar 2020 | 0.65 | +9.2% | Cons. · IFRS |
| FYE Mar 2021 | 0.59 | −9.4% | Cons. · IFRS |
| FYE Mar 2022 | 0.61 | +2.8% | Cons. · IFRS |
| FYE Mar 2023 | 0.59 | −3.4% | Cons. · IFRS |
| FYE Mar 2024 | 0.53 | −9.7% | Cons. · IFRS |
| FYE Mar 2025 | 0.57 | +7.0% | Cons. · IFRS |
| FYE Mar 2026 | 0.57 | −0.0% | Cons. · IFRS |
Cash flow statement Cash from operations, investment and financing, and what is left on hand
The three cash flows
¥ bnCash against debt
¥ bnOperating cash flow
FYE Mar 2026 ¥61bn
CAGR · 10 yrs −2.3%
| Fiscal year | Operating cash flow ¥ bn | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | 75.9 | n/a | Cons. · IFRS |
| FYE Mar 2018 | 150 | +97.3% | Cons. · IFRS |
| FYE Mar 2019 | 104 | −30.7% | Cons. · IFRS |
| FYE Mar 2020 | 103 | −0.9% | Cons. · IFRS |
| FYE Mar 2021 | 73.1 | −28.9% | Cons. · IFRS |
| FYE Mar 2022 | 118 | +60.9% | Cons. · IFRS |
| FYE Mar 2023 | -1.8 | −101.5% | Cons. · IFRS |
| FYE Mar 2024 | 56.0 | n/a | Cons. · IFRS |
| FYE Mar 2025 | 30.1 | −46.2% | Cons. · IFRS |
| FYE Mar 2026 | 61.3 | +103.6% | Cons. · IFRS |
Investing cash flow
FYE Mar 2026 -¥42bn
Average · 10 yrs -¥21bn
| Fiscal year | Investing cash flow ¥ bn | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | -28.6 | n/a | Cons. · IFRS |
| FYE Mar 2018 | 17.0 | n/a | Cons. · IFRS |
| FYE Mar 2019 | -7.9 | −146.5% | Cons. · IFRS |
| FYE Mar 2020 | -27.6 | n/a | Cons. · IFRS |
| FYE Mar 2021 | -36.1 | n/a | Cons. · IFRS |
| FYE Mar 2022 | -28.8 | n/a | Cons. · IFRS |
| FYE Mar 2023 | -22.7 | n/a | Cons. · IFRS |
| FYE Mar 2024 | -25.3 | n/a | Cons. · IFRS |
| FYE Mar 2025 | -10.1 | n/a | Cons. · IFRS |
| FYE Mar 2026 | -41.8 | n/a | Cons. · IFRS |
Financing cash flow
FYE Mar 2026 -¥61bn
Average · 10 yrs -¥57bn
| Fiscal year | Financing cash flow ¥ bn | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | -35.4 | n/a | Cons. · IFRS |
| FYE Mar 2018 | -81.9 | n/a | Cons. · IFRS |
| FYE Mar 2019 | -79.2 | n/a | Cons. · IFRS |
| FYE Mar 2020 | -104 | n/a | Cons. · IFRS |
| FYE Mar 2021 | -55.9 | n/a | Cons. · IFRS |
| FYE Mar 2022 | -49.0 | n/a | Cons. · IFRS |
| FYE Mar 2023 | -24.5 | n/a | Cons. · IFRS |
| FYE Mar 2024 | -22.7 | n/a | Cons. · IFRS |
| FYE Mar 2025 | -57.8 | n/a | Cons. · IFRS |
| FYE Mar 2026 | -61.1 | n/a | Cons. · IFRS |
Cash and equivalents
FYE Mar 2026 ¥245bn
CAGR · 10 yrs +3.1%
| Fiscal year | Cash and equivalents ¥ bn | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | 187 | n/a | Cons. · IFRS |
| FYE Mar 2018 | 271 | +44.8% | Cons. · IFRS |
| FYE Mar 2019 | 292 | +7.9% | Cons. · IFRS |
| FYE Mar 2020 | 254 | −12.9% | Cons. · IFRS |
| FYE Mar 2021 | 249 | −2.2% | Cons. · IFRS |
| FYE Mar 2022 | 310 | +24.5% | Cons. · IFRS |
| FYE Mar 2023 | 267 | −13.7% | Cons. · IFRS |
| FYE Mar 2024 | 305 | +14.0% | Cons. · IFRS |
| FYE Mar 2025 | 266 | −12.8% | Cons. · IFRS |
| FYE Mar 2026 | 245 | −7.6% | Cons. · IFRS |
Free cash flow
FYE Mar 2026 ¥20bn
CAGR · 10 yrs −9.4%
| Fiscal year | FCF ¥ bn | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | 47.3 | n/a | Cons. · IFRS |
| FYE Mar 2018 | 167 | +252.7% | Cons. · IFRS |
| FYE Mar 2019 | 95.8 | −42.5% | Cons. · IFRS |
| FYE Mar 2020 | 75.2 | −21.5% | Cons. · IFRS |
| FYE Mar 2021 | 37.0 | −50.8% | Cons. · IFRS |
| FYE Mar 2022 | 88.7 | +140.0% | Cons. · IFRS |
| FYE Mar 2023 | -24.5 | −127.6% | Cons. · IFRS |
| FYE Mar 2024 | 30.7 | n/a | Cons. · IFRS |
| FYE Mar 2025 | 20.0 | −34.7% | Cons. · IFRS |
| FYE Mar 2026 | 19.5 | −2.5% | Cons. · IFRS |
Operating cash flow margin
FYE Mar 2026 7.4%
Average · 10 yrs 11.5%
| Fiscal year | OCF margin % | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | 14.1 | n/a | Cons. · IFRS |
| FYE Mar 2018 | 24.9 | +10.9pp | Cons. · IFRS |
| FYE Mar 2019 | 16.1 | −8.8pp | Cons. · IFRS |
| FYE Mar 2020 | 14.8 | −1.4pp | Cons. · IFRS |
| FYE Mar 2021 | 11.3 | −3.5pp | Cons. · IFRS |
| FYE Mar 2022 | 15.5 | +4.2pp | Cons. · IFRS |
| FYE Mar 2023 | -0.2 | −15.8pp | Cons. · IFRS |
| FYE Mar 2024 | 7.5 | +7.8pp | Cons. · IFRS |
| FYE Mar 2025 | 3.8 | −3.7pp | Cons. · IFRS |
| FYE Mar 2026 | 7.4 | +3.6pp | Cons. · IFRS |
Net cash
FYE Mar 2026 ¥59bn
CAGR · 9 yrs −6.0%
| Fiscal year | Net cash ¥ bn | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | n/a | n/a | Cons. · IFRS |
| FYE Mar 2018 | 97.4 | n/a | Cons. · IFRS |
| FYE Mar 2019 | 153 | +57.1% | Cons. · IFRS |
| FYE Mar 2020 | 164 | +7.4% | Cons. · IFRS |
| FYE Mar 2021 | 159 | −3.3% | Cons. · IFRS |
| FYE Mar 2022 | 215 | +35.2% | Cons. · IFRS |
| FYE Mar 2023 | 141 | −34.2% | Cons. · IFRS |
| FYE Mar 2024 | 145 | +2.9% | Cons. · IFRS |
| FYE Mar 2025 | 78.0 | −46.3% | Cons. · IFRS |
| FYE Mar 2026 | 59.3 | −24.0% | Cons. · IFRS |
Shares and share price Shares outstanding, price, market capitalisation and the valuation multiples
Market capitalisation
FYE Mar 2026 ¥1.42tn
Change · 10 yrs −¥289bn
| Fiscal year | Market capitalisation ¥ bn | Basis |
|---|---|---|
| FYE Mar 2017 | 1,709 | n/a |
| FYE Mar 2018 | 2,011 | n/a |
| FYE Mar 2019 | 1,843 | n/a |
| FYE Mar 2020 | 2,352 | n/a |
| FYE Mar 2021 | 2,200 | n/a |
| FYE Mar 2022 | 1,682 | n/a |
| FYE Mar 2023 | 2,226 | n/a |
| FYE Mar 2024 | 1,843 | n/a |
| FYE Mar 2025 | 1,209 | n/a |
| FYE Mar 2026 | 1,421 | n/a |
Share price year-end close
FYE Mar 2026 4,871¥
Change · 10 yrs −893¥
| Fiscal year | Share price ¥ | Basis |
|---|---|---|
| FYE Mar 2017 | 5,764 | n/a |
| FYE Mar 2018 | 6,782 | n/a |
| FYE Mar 2019 | 6,213 | n/a |
| FYE Mar 2020 | 7,931 | n/a |
| FYE Mar 2021 | 7,419 | n/a |
| FYE Mar 2022 | 5,670 | n/a |
| FYE Mar 2023 | 7,504 | n/a |
| FYE Mar 2024 | 6,216 | n/a |
| FYE Mar 2025 | 4,145 | n/a |
| FYE Mar 2026 | 4,871 | n/a |
EPS earnings per share
FYE Mar 2026 136.78¥
Change · 10 yrs −0.85¥
| Fiscal year | EPS ¥ | Basis |
|---|---|---|
| FYE Mar 2017 | 137.63 | Cons. |
| FYE Mar 2018 | 181.18 | Cons. |
| FYE Mar 2019 | 221.34 | Cons. |
| FYE Mar 2020 | 425.01 | Cons. |
| FYE Mar 2021 | 146.34 | Cons. |
| FYE Mar 2022 | 167.27 | Cons. |
| FYE Mar 2023 | 193.31 | Cons. |
| FYE Mar 2024 | 147.86 | Cons. |
| FYE Mar 2025 | 163.76 | Cons. |
| FYE Mar 2026 | 136.78 | Cons. |
BPS book value per share
FYE Mar 2026 2,992.85¥
Change · 10 yrs +1,021.52¥
| Fiscal year | BPS ¥ | Basis |
|---|---|---|
| FYE Mar 2017 | 1,971.33 | Cons. · IFRS |
| FYE Mar 2018 | 1,932.34 | Cons. · IFRS |
| FYE Mar 2019 | 2,037.52 | Cons. · IFRS |
| FYE Mar 2020 | 2,203.97 | Cons. · IFRS |
| FYE Mar 2021 | 2,282.26 | Cons. · IFRS |
| FYE Mar 2022 | 2,448.39 | Cons. · IFRS |
| FYE Mar 2023 | 2,621.16 | Cons. · IFRS |
| FYE Mar 2024 | 2,873.74 | Cons. · IFRS |
| FYE Mar 2025 | 2,800.85 | Cons. · IFRS |
| FYE Mar 2026 | 2,992.85 | Cons. · IFRS |
PER price-to-earnings ratio
FYE Mar 2026 35.61×
Average · 10 yrs 35.24×
| Fiscal year | PER × | Basis |
|---|---|---|
| FYE Mar 2017 | 41.88 | Cons. |
| FYE Mar 2018 | 37.43 | Cons. |
| FYE Mar 2019 | 28.07 | Cons. |
| FYE Mar 2020 | 18.66 | Cons. |
| FYE Mar 2021 | 50.70 | Cons. |
| FYE Mar 2022 | 33.90 | Cons. |
| FYE Mar 2023 | 38.82 | Cons. |
| FYE Mar 2024 | 42.04 | Cons. |
| FYE Mar 2025 | 25.31 | Cons. |
| FYE Mar 2026 | 35.61 | Cons. |
PBR price-to-book ratio
FYE Mar 2026 1.53×
Average · 10 yrs 2.51×
| Fiscal year | PBR × | Basis |
|---|---|---|
| FYE Mar 2017 | 2.82 | Cons. |
| FYE Mar 2018 | 3.27 | Cons. |
| FYE Mar 2019 | 2.83 | Cons. |
| FYE Mar 2020 | 3.35 | Cons. |
| FYE Mar 2021 | 3.03 | Cons. |
| FYE Mar 2022 | 2.17 | Cons. |
| FYE Mar 2023 | 2.69 | Cons. |
| FYE Mar 2024 | 2.04 | Cons. |
| FYE Mar 2025 | 1.39 | Cons. |
| FYE Mar 2026 | 1.53 | Cons. |
Workforce and productivity Headcount, pay and what each employee accounts for
Group employees
FYE Mar 2026 10,543people
Change · 10 yrs +91 people
| Fiscal year | Group employees people | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | 10,452 | n/a | Cons. |
| FYE Mar 2018 | 10,456 | −0.0% | Cons. |
| FYE Mar 2019 | 10,683 | +2.2% | Cons. |
| FYE Mar 2020 | 10,998 | +2.9% | Cons. |
| FYE Mar 2021 | 11,237 | +2.2% | Cons. |
| FYE Mar 2022 | 11,322 | +0.8% | Cons. |
| FYE Mar 2023 | 11,076 | −2.2% | Cons. |
| FYE Mar 2024 | 11,067 | −0.1% | Cons. |
| FYE Mar 2025 | 10,917 | −1.4% | Cons. |
| FYE Mar 2026 | 10,543 | −3.4% | Cons. |
Parent-company employees
FYE Mar 2026 2,979people
Change · 10 yrs −267 people
| Fiscal year | Parent-company employees people | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | 3,246 | n/a | Parent |
| FYE Mar 2018 | 3,172 | −2.3% | Parent |
| FYE Mar 2019 | 3,140 | −1.0% | Parent |
| FYE Mar 2020 | 2,953 | −6.0% | Parent |
| FYE Mar 2021 | 3,005 | +1.8% | Parent |
| FYE Mar 2022 | 3,034 | +1.0% | Parent |
| FYE Mar 2023 | 3,043 | +0.3% | Parent |
| FYE Mar 2024 | 2,984 | −1.9% | Parent |
| FYE Mar 2025 | 2,998 | +0.5% | Parent |
| FYE Mar 2026 | 2,979 | −0.6% | Parent |
Average annual pay parent company
FYE Mar 2026 ¥11.2m
Change · 10 yrs +¥0.8m
| Fiscal year | Average annual pay ¥ m | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | 10.4 | n/a | Parent |
| FYE Mar 2018 | 10.4 | +0.6% | Parent |
| FYE Mar 2019 | 11.0 | +5.2% | Parent |
| FYE Mar 2020 | 10.4 | −5.7% | Parent |
| FYE Mar 2021 | 10.4 | +0.5% | Parent |
| FYE Mar 2022 | 9.2 | −11.7% | Parent |
| FYE Mar 2023 | 10.5 | +14.1% | Parent |
| FYE Mar 2024 | 10.5 | +0.3% | Parent |
| FYE Mar 2025 | 10.6 | +0.2% | Parent |
| FYE Mar 2026 | 11.2 | +6.4% | Parent |
Average age
FYE Mar 2026 44.5years
Change · 8 yrs −0.7 years
| Fiscal year | Average age years | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | n/a | n/a | Parent |
| FYE Mar 2018 | n/a | n/a | Parent |
| FYE Mar 2019 | 45.2 | n/a | Parent |
| FYE Mar 2020 | 44.4 | −1.8% | Parent |
| FYE Mar 2021 | 43.9 | −1.1% | Parent |
| FYE Mar 2022 | 43.0 | −2.1% | Parent |
| FYE Mar 2023 | 43.6 | +1.4% | Parent |
| FYE Mar 2024 | 44.2 | +1.4% | Parent |
| FYE Mar 2025 | 44.6 | +0.9% | Parent |
| FYE Mar 2026 | 44.5 | −0.2% | Parent |
Average length of service
FYE Mar 2026 18.5years
Change · 10 yrs −1.4 years
| Fiscal year | Average length of service years | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | 19.9 | n/a | Parent |
| FYE Mar 2018 | 20.2 | +1.5% | Parent |
| FYE Mar 2019 | 20.6 | +2.0% | Parent |
| FYE Mar 2020 | 19.4 | −5.8% | Parent |
| FYE Mar 2021 | 18.5 | −4.6% | Parent |
| FYE Mar 2022 | 17.4 | −5.9% | Parent |
| FYE Mar 2023 | 17.9 | +2.9% | Parent |
| FYE Mar 2024 | 18.5 | +3.4% | Parent |
| FYE Mar 2025 | 18.5 | −0.0% | Parent |
| FYE Mar 2026 | 18.5 | −0.0% | Parent |
Revenue per employee
FYE Mar 2026 ¥78.3m
Change · 10 yrs +¥26.7m
| Fiscal year | Revenue per employee ¥ m | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | 51.6 | n/a | Cons. |
| FYE Mar 2018 | 57.4 | +11.3% | Cons. |
| FYE Mar 2019 | 60.2 | +4.9% | Cons. |
| FYE Mar 2020 | 63.2 | +5.1% | Cons. |
| FYE Mar 2021 | 57.5 | −9.1% | Cons. |
| FYE Mar 2022 | 66.8 | +16.2% | Cons. |
| FYE Mar 2023 | 67.2 | +0.6% | Cons. |
| FYE Mar 2024 | 67.0 | −0.3% | Cons. |
| FYE Mar 2025 | 72.3 | +7.9% | Cons. |
| FYE Mar 2026 | 78.3 | +8.3% | Cons. |
Operating profit per employee
FYE Mar 2026 ¥4.2m
Change · 10 yrs −¥1.5m
| Fiscal year | OP per employee ¥ m | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | 5.7 | n/a | Cons. |
| FYE Mar 2018 | 7.4 | +30.7% | Cons. |
| FYE Mar 2019 | 8.1 | +9.2% | Cons. |
| FYE Mar 2020 | 11.4 | +41.5% | Cons. |
| FYE Mar 2021 | 4.6 | −59.6% | Cons. |
| FYE Mar 2022 | 4.7 | +3.1% | Cons. |
| FYE Mar 2023 | 3.6 | −23.9% | Cons. |
| FYE Mar 2024 | 4.8 | +33.5% | Cons. |
| FYE Mar 2025 | 5.0 | +3.2% | Cons. |
| FYE Mar 2026 | 4.2 | −16.0% | Cons. |
Disclaimer
- Figures are reproduced as filed and are not restated: a change of accounting standard or of consolidation basis moves the series without anything happening to the business. Where that happened, the table says so in place of the year-on-year figure.
- Ratios and per-employee figures are computed from the filed lines rather than taken from the filing, and use year-end balances rather than averages.
Accuracy, liability, reuse and privacy — the full disclaimer →
Data API
Eisai’s history, presidents and financials
are published as static JSON — no key, plain GET. One API per
public page, and one per section where a page carries several tables.
Full specification →
/api/4523/company.json ·/api/4523/history.json ·/api/4523/ceo.json ·/api/4523/financials.json ·/api/4523/financials/segment.json ·/api/4523/financials/pl.json ·/api/4523/financials/cf.json ·/api/4523/financials/bs.json ·/api/4523/financials/employee.json ·/api/4523/financials/stock.json ·/api/4523/financials.csv ·/api/4523/financials_history.csv
/api/companies.json ·/api/decisions.json ·/api/api-manifest.json